SCHEMBL102326

SCHEMBL102326

CCCC[CH]CCCCCCCCCCCCCCCCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.55
THRB P10828 1/20 0.53
FAAH O00519 2/20 0.48
TRPV1 Q8NER1 1/20 0.48
DNM1 Q05193 3/20 0.47
ALDH1A1 P00352 1/20 0.45
EP300 Q09472 1/20 0.42
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
APEX1 P27695 1/20 0.41
CYP2C19 P33261 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL201880 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL99730 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL99494 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL25170900 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL201327 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL25176506 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL25170220 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL25170905 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL100509 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL103528 1.00 TSHR (0.55) TSHRTHRBFAAHTRPV1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118063537-A Prodrugs of directed lymphatics 莫纳什大学 2024-05-24 CN disclosed
WO-2024071045-A1 POLYCARBONATE RESIN AND MOLDED ARTICLE CONTAINING SAME 富士フイルム株式会社 2024-04-04 WO disclosed
CN-108137482-B Prodrugs of directed lymphatics 莫纳什大学 2024-03-15 CN disclosed
EP-3183250-B1 PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL CLAP CO LTD (KR) 2023-10-04 EP disclosed
WO-2023099634-A1 LUBRICANT COMPOSITIONS TOTALENERGIES ONETECH (FR) 2023-06-08 WO disclosed
WO-2023078950-A1 LIPID NANOPARTICLES FOR OLIGONUCLEOTIDE DELIVERY ZIPHIUS VACCINES NV (BE) 2023-05-11 WO disclosed
WO-2023078954-A1 LIPID NANOPARTICLES FOR OLIGONUCLEOTIDE DELIVERY ZIPHIUS VACCINES NV (BE) 2023-05-11 WO disclosed
WO-2023078946-A1 LIPID NANOPARTICLES FOR OLIGONUCLEOTIDE DELIVERY ZIPHIUS VACCINES NV (BE) 2023-05-11 WO disclosed
US-11326023-B2 Aromatic polycarbonate resin, method for producing same, and aromatic dihydroxy compound MITSUBISHI CHEMICAL CORPORATION (JP) 2022-05-10 US disclosed
EP-3183757-B1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM CLAP CO LTD (KR) 2022-05-04 EP disclosed
US-5665338-A KERATIN-REDUCING SUBSTANCE, NONIONIC AMPHIPHATIC COMPOUND KAO CORPORATION (JP) 1997-09-09 US disclosed
EP-0765862-A1 FATTY ACID ESTER OF ETHERIFIED POLYHYDRIC ALCOHOL Kao Corporation (JP) 1997-04-02 EP disclosed
EP-0706788-A1 Acid dye containing colorants KAO CORPORATION (JP) 1996-04-17 EP disclosed
EP-0682935-A2 Hair cosmetics KAO CORPORATION (JP) 1995-11-22 EP disclosed
EP-0662314-A1 Method of hair treatment Kao Corporation (JP) 1995-07-12 EP disclosed
US-5429820-A A POLYOL GLYCERYL ETHER WHICH PROVIDES MOISTURIZING EFFECTS AND EXTENSIBILITY TO COSMETICS KAO CORPORATION (JP) 1995-07-04 US disclosed
EP-0512270-A2 Cosmetic composition KAO CORPORATION (JP) 1992-11-11 EP disclosed
EP-0345697-A2 Magnetic recording medium FUJI PHOTO FILM CO., LTD. (JP) 1989-12-13 EP disclosed
EP-0305114-A1 Heat treating oil NIPPON OIL CO. LTD. (JP) 1989-03-01 EP disclosed
US-3988292-A A TRIAZINE DERIVATIVE TEIJIN LIMITED (JA) 1976-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11326023-B2 Aromatic polycarbonate resin, method for producing same, and aromatic dihydroxy compound SUV39H2, ASH2L, PAH TSHR 4387/4885THRB 4704/4885FAAH 1295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.